Cell-free synthesis companies develop technologies that produce proteins, DNA and other biological molecules without relying on intact living cells during the production step. These approaches use cell extracts, purified enzymes or controlled biochemical reactions for research, discovery and manufacturing.
This category includes organisations working on:
Browse 10 UK cell-free synthesis companies below.
Enzymatic synthetic DNA manufacture for gene therapy and molecular biology
NunaBio is a specialist DNA synthesis company developing a cell-free enzymatic platform for scalable production of synthetic DNA, including long oligonucleotides, whole genes and DNA fragments. Its technology avoids the plasmid and primer-dependent steps that constrain conventional phosphoramidite chemistry, enabling…
Benchtop platform for rapid cell-free protein expression and screening
Nuclera is a Cambridge-based biotechnology company developing benchtop systems for rapid protein expression and screening. Its discovery platform integrates cell-free protein synthesis, digital microfluidics, and automated construct screening to deliver soluble, active proteins in under 48 hours. The system is…
Engineered bacteriophages for precision antimicrobial discovery
BioPhoundry is an engineering biology company developing bacteriophage-based technologies for precision antimicrobial research. Its Phax platform combines machine learning, synthetic biology and cell-free production to accelerate phage discovery and engineering. The company aims to generate tailored phages for…
Developing cell-free long-DNA manufacturing for precision breeding
Newcleic develops cell-free methods for manufacturing long DNA sequences, drawing on biochemical engineering research at UCL. Its technology aims to make complex DNA production more reliable, accessible and sustainable. Its initial focus is agricultural biotechnology, supporting precision breeding and plant…
GMP-grade cell-free synthetic DNA for genetic medicines
4basebio is a biotechnology manufacturing company producing GMP-grade synthetic DNA for use in cell and gene therapies, mRNA vaccines and genome editing applications. Using an enzymatic, cell-free synthesis process, the company manufactures application-specific linear DNA constructs that overcome the purity and…
Enzymatic DNA synthesis for pharmaceutical and biotechnology research
Camena Bioscience is a synthetic biology company that develops and supplies enzymatic gene synthesis technology to pharmaceutical and biotechnology customers. Its multi-enzymatic approach to DNA synthesis offers substantially improved accuracy and access to longer, more complex sequences compared to conventional…
Technology innovation centre for process scale-up and manufacturing
CPI is a UK innovation centre and social enterprise that helps companies develop, scale and commercialise new products and processes across pharmaceuticals, bioprocessing, health technology and sustainable manufacturing. As a founding member of the High Value Manufacturing Catapult, CPI provides access to specialist…
Cell-free biocatalyst platform for sustainable industrial chemical manufacturing
FabricNano is an industrial biotechnology company developing cell-free enzyme catalysts for chemical manufacturing. Its immobilisation engineering platform uses high-throughput screening to identify scalable support materials that improve enzyme stability and activity. Predictive Immobilisation Plates enable…
Microbial CRO for natural product discovery and fermentation scale-up
Isomerase is a company providing contract research and development services centred on microbial synthetic biology, with expertise spanning natural product discovery, enzyme engineering, strain bioengineering, and fermentation process development. It serves clients across pharma, biotech, agritech, food and consumer…
Cell-free enzymatic DNA manufacturing for genetic medicines
Touchlight is a contract development and manufacturing organisation producing synthetic DNA for genetic medicine applications using a cell-free enzymatic process. Its linear, covalently closed DNA constructs are free from bacterial sequences and antibiotic resistance genes, offering regulatory and safety advantages…